Birkirkara, Malta – October 01, 2026 -- Gentoo Media Inc. has locked in commitments worth EUR 100 million to refinance its EUR 91.5 million senior secured bonds maturing 18 December 2026, combining a new EUR 50 million term loan with a fully underwritten EUR 50 million share issue.
San Diego – October 01, 2026 -- Halozyme Therapeutics (Nasdaq: HALO) has appointed James "Jim" Daly to its Board of Directors, returning a veteran biopharmaceutical commercial executive to help steer the company's drug-delivery technology expansion.
Daly previously served on Halozyme's board and has held senior commercial leadership roles at Incyte Corporation, Amgen and Glaxo Wellcome/GlaxoSmithKline. He was Executive Vice President and Chief Commercial Officer of Incyte from 2012 to 2015, following a decade at Amgen where he most recently served as Senior Vice President, North America Commercial Operations, Global Marketing and Commercial Development. Earlier, he spent more than 16 years at Glaxo Wellcome/GlaxoSmithKline, including as Senior Vice President and General Manager of the U.S. respiratory business.
Chicago – – October 01, 2026 -- Cars.com Inc. (NYSE: CARS) has appointed Trent Ziegler as Chief Financial Officer-Designate, effective October 01, 2026, with formal succession to the CFO role on October 01, 2026.
The staggered handover is designed to ensure an orderly transition of financial leadership at the automotive marketplace operator. Jain will remain available to the company in an advisory capacity for nearly five months following the formal changeover.
Hayward, Calif. – October 01, 2026 -- Ultra Clean Holdings, Inc. (Nasdaq: UCTT) appointed Alexander Davern to its Board of Directors effective October 01, 2026, adding more than three decades of industrial and technology leadership experience to its governance ranks.
During his tenure at National Instruments, Davern helped scale the company's operations across more than 50 countries, gaining direct oversight of finance, operations and global expansion in a technology-manufacturing environment.
Vancouver – – September 30, 2026 -- Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) has extended its shareholder proxy voting deadline to September 30, 2026 at 4:00 p.m. Pacific time, after approving a further revision to a special resolution governing amendments to the Company's corporate Articles ahead of its annual general and special meeting scheduled for October 2, 2026.
Silvercorp has amended Article 16, which governs how shareholders nominate individuals for election to the Board. Having initially proposed limiting the information required to assess a nominee's independence, the Company has now gone further, removing its ability to request any nominee information beyond items specifically enumerated in Article 16, paragraph 4. A redline of the proposed changes was filed on SEDAR+ on September 29, 2026 under "Other Securityholder Documents."
Kelowna, BC – September 30, 2026 -- Doseology Sciences Inc. (CSE: MOOD, OTCQB: DOSEF, FSE: VU70) has appointed Kareem Baalbaki as interim CEO, interim CFO and director, alongside Jeremy Wright as a new board director, replacing outgoing CEO Chris Jackson and CFO Chris Cherry, who have both resigned.
Baalbaki previously served as Chief Supply Chain Officer at Revive Superfoods, where he helped grow the frozen CPG platform's annual revenue from approximately $10 million to $150 million. The Toronto-based executive holds more than a decade of operations and supply-chain experience, including restructuring underperforming businesses and advising boards on governance and organizational design. He holds a Master of Science in International Business from the University of Lincoln in the United Kingdom.
Kista, Sweden – September 30, 2026 -- Sivers Semiconductors AB has called an Extraordinary General Meeting for 22 October 2026 to replace auditor Deloitte AB with Ernst & Young AB, a move tied to the company's plan for a dual listing on U.S. capital markets expected in the first half of 2027.
Deloitte has served as Sivers' auditor for ten years, the maximum term allowed under Article 17 of EU Regulation No 537/2014 for public-interest entities. The Audit Committee recommended the change, which the Nomination Committee approved unanimously, framing EY's experience with SEC reporting requirements and U.S. capital markets activity for Swedish listed companies as the deciding factor. The Nomination Committee stated the switch does not stem from any disagreement over accounting or financial reporting.
Zurich – September 29, 2026 -- Amcor (NYSE: AMCR, ASX: AMC) confirmed that Graeme Liebelt will step down as Chairman after nearly 13 years, with the Board electing Tom Long as his successor effective at the company's Nov. 11, 2026 annual meeting.
Liebelt will not stand for re-election and will retire from Amcor's Board of Directors at the close of his current term. He chaired Amcor plc and its predecessor entity for nearly 13 years, overseeing expansion of the company's product portfolio and sustainability capabilities.
Long has served as an independent non-executive director on Amcor's Board since 2017. He was previously Chief Executive Officer of MillerCoors, LLC, and led Miller Brewing Company before its 2008 merger with Coors. Long currently chairs the Board of Wolverine Worldwide, Inc.
Valencia – – September 29, 2026 -- Arthex Biotech has appointed Glenn Sblendorio, former CEO of IVERIC bio, as Chairman of its Board of Directors as the clinical-stage RNA therapeutics company advances its lead program ATX-01 through Phase I/IIa trials for myotonic dystrophy type 1 (DM1).
Sblendorio most recently led IVERIC bio, Inc. as CEO until its acquisition by Astellas Pharma, Inc. He previously served as President and Chief Financial Officer of The Medicines Company through its acquisition by Novartis, and as Executive Vice President and CFO of Eyetech Pharmaceuticals, Inc. until it was acquired by OSI Pharmaceuticals, Inc. Earlier in his career he was a Managing Director at MPM Capital Advisors.
Johannesburg – September 25, 2026 -- Sasol Limited confirmed that non-executive director Rhidwaan Gasant has resigned from the Board for personal reasons, effective immediately upon acceptance on 25 September 2026.
The change was disclosed in compliance with paragraph 6.71 of the JSE Listings Requirements and paragraph 6.42 of the JSE Debt and Specialist Securities Listings Requirements, which mandate shareholder and noteholder notification of director departures.
Alongside his board resignation, Gasant steps down from his positions on Sasol's Audit Committee and Remuneration Committee, effective the same date.
Board Chairman Ms Dube thanked Gasant for his service and contribution during his tenure, citing the insights and experience he brought to board deliberations.